Nom du produit:4-(4-(tert-butyl)benzoyl)-3-propyl-3,4-dihydroquinoxalin-2(1H)-one

IUPAC Name:4-(4-tert-butylbenzoyl)-3-propyl-1,2,3,4-tetrahydroquinoxalin-2-one

CAS:1008253-78-8
Formule moléculaire:C22H26N2O2
Pureté:95%+
Numéro de catalogue:CM1047391
Poids moléculaire:350.46

Unité d'emballage Stock disponible Prix($) Quantité
CM1047391-10mg in stock ǤƓʼn

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:1008253-78-8
Formule moléculaire:C22H26N2O2
Point de fusion:-
Code SMILES:O=C1NC2=C(C=CC=C2)N(C(C3=CC=C(C(C)(C)C)C=C3)=O)C1CCC
Densité:
Numéro de catalogue:CM1047391
Poids moléculaire:350.46
Point d'ébullition:
N° Mdl:
Stockage:

Category Infos

Quinoxalines
Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.